Brought to you by:
Previously described patient-centered clinical success measure after revascularization for diabetic foot wounds may be ‘too strict’
Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest the measure on which the study was based may define clinical success too strictly given the…
DETOUR I two-year outcomes: ‘Excellent’ functional improvement in complex PAD cohort
During a late-breaking data session at this year’s Vascular Interventional Advances virtual annual meeting (VIVA 2020) Nov 6–8, Ehrin Armstrong, MD, a professor of cardiology at the University of Colorado, Denver, presented two-year outcomes from the DETOUR I trial for…
Abstracts for VRIC, VAM 2021
Calling surgeons and scientists: Your research is wanted. Submission sites are now open for two annual SVS meetings in 2021, the Vascular Research Initiatives Conference (VRIC) and the Vascular Annual Meeting (VAM). The VRIC submission site will close Jan. 6,…
Case study: Putting the SVS Branding Toolkit into action
William Shutze, MD, a member in community practice in Dallas, has lost no time in putting the new SVS Branding Toolkit to use. In fact, he was experimenting with it during the SVS Town Hall in mid-September at which it…
Give people a fair chance and watch the results
Ten years ago when we wrote a paper on diversity that was published in the Journal of Vascular Surgery (JVS), it barely caused a ripple. Entitled “Diversity in membership and leadership positions in a regional vascular society,” it was co-authored…
Intravascular lithotripsy ‘superior’ to PTA in acute procedural success out to 30 days
The DISRUPT PAD III randomized controlled trial (RCT) provides the largest level-one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William Gray, MD, an interventional cardiologist at Main Line Health, Philadelphia, during the second and final late-breaking data…
Anatomy of a branding campaign: Making vascular surgery more visible
Members asked; SVS listened. The Society for Vascular Surgery (SVS) has launched a Branding Toolkit to help its members brand the specialty in order to elevate and differentiate their practices. This first set of branding tools tells referring physicians what…
Latest VOYAGER PAD analysis finds no mortality and improved limb outcomes in drug-coated device cohort
Given the absence of a safety signal in data from the VOYAGER PAD trial, a new analysis examined the potential benefit of drug-coated device versus non-drug-coated device treatment for reducing limb outcomes. Connie Hess, MD, an associate professor of cardiology…
New committee needs volunteers
The Society for Vascular Surgery (SVS) has extended the deadline for volunteers to apply to its new Communications Committee. The Society is seeking members who are currently not on an SVS committee and have a desire to shape and align…
Utilize new SVS Branding Toolkit
The new SVS Branding Toolkit—a robust set of tools designed to help members communicate their roles in comprehensive vascular care—is now available exclusively and at no cost to members of the Society for Vascular Surgery (SVS). Additionally, most are customizable…